Qlucore Expands its Marketing Efforts with New High-Profile Appointment to Board - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Qlucore Expands its Marketing Efforts with New High-Profile Appointment to Board

13th November 2009

Qlucore, a world leader in the development of bioinformatics software, has appointed Pia Gideon, the former vice-president of marketing and communication at Ericsson, to its board of directors.

“Qlucore is now ready for the next phase of expansion, and we are thrilled to have Pia Gideon joining us, as we know that Qlucore will benefit from her extensive experience in global marketing and communications,” says Cecilia Schelin Seidegård, chairman of the board.

Qlucore is best known for its highly intuitive Qlucore Omics Explorer product, which enables instant analysis and adds increased creativity to research, thanks to the software’s impressive speed and statistical capability. Qlucore was founded in 2007 and has already delivered its solutions to leading research organisations and pharmaceutical companies all over the world.

Qlucore is a privately-owned company in which the founders and management hold a substantial portion of the shares. The company has today confirmed that it has raised SEK1.3m (approximately £115,000) in fresh capital which will be used to intensify its sales and marketing efforts.

“This additional funding is further proof of our investors’ confidence and belief in Qlucore, as well as their commitment to supporting our next phase of growth and development,” says Carl-Johan Ivarsson, president of Qlucore.

Qlucore has already gained a global reputation for its leading-edge data analysis software, as it allows the actual researchers – the people with the most biological insight – to study the data and to look for patterns and structures. In addition, because Qlucore Omics Explorer allows researchers to explore different hypotheses and alternative scenarios within seconds, the software is already helping to play a key role in unveiling important new discoveries.

More About This Company